US equities
|
MU
$877.55
▲+2.46%
NVDA
$210.96
▼-0.59%
SPCX
$147.49
▲+1.89%
AAPL
$347.73
▼-0.14%
TSLA
$372.22
▼-0.63%
SNDK
$1,238.03
▼-1.82%
META
$642.62
▼-0.96%
AMD
$516.79
▲+1.74%
MU
$877.55
▲+2.46%
NVDA
$210.96
▼-0.59%
SPCX
$147.49
▲+1.89%
AAPL
$347.73
▼-0.14%
TSLA
$372.22
▼-0.63%
SNDK
$1,238.03
▼-1.82%
META
$642.62
▼-0.96%
AMD
$516.79
▲+1.74%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Nicholas Sosiak
Recent news which mentions Nicholas Sosiak
Cannara Biotech Reports 51% YoY Revenue Increase In Q2, Wider Net Loss
May 01, 2024
Tickers
LOVE
LOVE
LOVFF
NEWS
Tags
News
Market News
Cannabis
From
Benzinga
Cannara Biotech Secures An Additional $10M In Non-Dilutive Capital With Its Lead Credit Provider, BMO Commercial Banking
May 04, 2023
Tickers
LOVFF
Tags
Nicholas Sosiak
Benzinga
Penny Stocks
From
Benzinga
Cannara Biotech Q1 Revenue Grows 57% YoY To $7.7M, What About Adjusted EBITDA?
January 23, 2023
Tickers
LOVFF
Tags
Earnings
Markets
News
From
Benzinga
Cannara Biotech Enters Into The British Columbia Cannabis Market And Launches New Products
September 20, 2022
Tickers
LOVFF
Tags
Markets
News
Market News
From
Benzinga
Cannara Biotech Closes $50 Million Credit Facility Led By BMO Commercial Banking
June 02, 2022
Tickers
LOVFF
Tags
Market News
News
Cannabis
From
Benzinga